Myomo (NYSEAMERICAN:MYO) Director Buys $27,026.63 in Stock

Myomo, Inc. (NYSEAMERICAN:MYO) Director Joseph Jr. Manko purchased 30,367 shares of the business’s stock in a transaction dated Friday, May 15th. The shares were bought at an average price of $0.89 per share, with a total value of $27,026.63. Following the purchase, the director directly owned 2,309,775 shares of the company’s stock, valued at approximately $2,055,699.75. The trade was a 1.33% increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink.

Myomo Price Performance

Myomo stock opened at $0.91 on Thursday. Myomo, Inc. has a 12 month low of $0.61 and a 12 month high of $3.39. The company has a debt-to-equity ratio of 1.21, a current ratio of 2.73 and a quick ratio of 2.36. The business has a 50 day simple moving average of $0.77 and a 200-day simple moving average of $0.84. The stock has a market capitalization of $35.35 million, a PE ratio of -2.54 and a beta of 1.39.

Analyst Upgrades and Downgrades

Separately, Craig Hallum restated a “buy” rating on shares of Myomo in a research note on Tuesday, March 10th. Four equities research analysts have rated the stock with a Buy rating, According to data from MarketBeat, the company has an average rating of “Buy” and a consensus price target of $7.67.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of MYO. Cubist Systematic Strategies LLC raised its position in Myomo by 157.4% in the first quarter. Cubist Systematic Strategies LLC now owns 49,101 shares of the company’s stock worth $236,000 after acquiring an additional 30,028 shares in the last quarter. Dynamic Technology Lab Private Ltd purchased a new position in Myomo in the first quarter worth $75,000. Jane Street Group LLC raised its position in Myomo by 84.2% in the first quarter. Jane Street Group LLC now owns 162,658 shares of the company’s stock worth $782,000 after acquiring an additional 74,338 shares in the last quarter. Acadian Asset Management LLC purchased a new position in Myomo in the first quarter worth $114,000. Finally, Geode Capital Management LLC raised its position in Myomo by 160.8% in the second quarter. Geode Capital Management LLC now owns 669,281 shares of the company’s stock worth $1,446,000 after acquiring an additional 412,631 shares in the last quarter. Hedge funds and other institutional investors own 44.99% of the company’s stock.

Myomo Company Profile

Myomo, Inc (NYSE American: MYO) is a medical robotics company specializing in developing and commercializing powered orthotic devices designed to restore mobility and function for individuals with upper-limb weakness. The company’s flagship product, the MyoPro®, is an FDA-cleared, wearable robotic orthosis that leverages proprietary sensors and actuators to detect and amplify users’ own muscle signals, enabling patients with conditions such as stroke, spinal cord injury, muscular dystrophy and other neuromuscular disorders to perform daily activities with greater independence.

Myomo markets the MyoPro through a network of licensed orthotic and prosthetic professionals, clinics and hospitals across North America.